Ioannis BOUKOVINAS | Bioclinic Thessaloniki, Thessaloníki | Oncology Unit
Ioannis VARTHALITIS | Head of Department | 1st Medical Oncology Dept
Ioannis VARTHALITIS | Head of Department | 1st Medical Oncology Dept
Ioannis VARTHALITIS | Head of Department | 1st Medical Oncology Dept
PDF) FEC versus sequential docetaxel followed by epirubicin/cyclophosphamide as adjuvant chemotherapy in women with axillary node-positive early breast cancer: a randomized study of the Hellenic Oncology Research Group (HORG) | I. Varthalitis
Ioannis VARTHALITIS | Head of Department | 1st Medical Oncology Dept
PDF) AlphaB-crystallin is a marker of aggressive breast cancer behavior but does not independently predict for patient outcome: A combined analysis of two randomized studies
I Dimitriadis's research works
PDF) Case-Mix Adjustment Approach to Benchmarking Prevalence Rates of Nosocomial Infection in Hospitals in Cyprus and Greece
Ioannis VARTHALITIS · Head of Department · 1st Medical Oncology Dept
PDF) A randomized phase III study of the docetaxel/carboplatin combination versus docetaxel single-agent as second line treatment for patients with advanced/metastatic Non-Small Cell Lung Cancer
Effects of caspase inhibitors and thiol supplements on doxorubicin... | Download Scientific Diagram
Unadjusted (Observed) and Case Mix-Adjusted Prevalence Rates for... | Download Table
Ioannis VARTHALITIS | Head of Department | 1st Medical Oncology Dept
Ioannis VARTHALITIS | Head of Department | 1st Medical Oncology Dept
Endogenous and Exogenous Risk Factors of Patients Surveyed for... | Download Table
Unadjusted (Observed) and Case Mix-Adjusted Prevalence Rates for... | Download Table
Univariate and Multivariate Analysis of Risk Factors for Mortality... | Download Table
a Number of delayed cycles (\2 cycles, C2 cycles), b number of delayed... | Download Scientific Diagram